It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Normal brain functioning emerges from a complex interplay among regions forming networks. In epilepsy, these networks are disrupted causing seizures. Highly connected nodes in these networks are epilepsy surgery targets. Here, we assess whether functional connectivity (FC) using intracranial electroencephalography can quantify brain regions epileptogenicity and predict surgical outcome in children with drug resistant epilepsy (DRE). We computed FC between electrodes on different states (i.e. interictal without spikes, interictal with spikes, pre-ictal, ictal, and post-ictal) and frequency bands. We then estimated the electrodes’ nodal strength. We compared nodal strength between states, inside and outside resection for good- (n = 22, Engel I) and poor-outcome (n = 9, Engel II–IV) patients, respectively, and tested their utility to predict the epileptogenic zone and outcome. We observed a hierarchical epileptogenic organization among states for nodal strength: lower FC during interictal and pre-ictal states followed by higher FC during ictal and post-ictal states (p < 0.05). We further observed higher FC inside resection (p < 0.05) for good-outcome patients on different states and bands, and no differences for poor-outcome patients. Resection of nodes with high FC was predictive of outcome (positive and negative predictive values: 47–100%). Our findings suggest that FC can discriminate epileptogenic states and predict outcome in patients with DRE.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Cook Children’s Health Care System, Jane and John Justin Institute for Mind Health Neurosciences Center, Fort Worth, USA (GRID:grid.470289.0); The University of Texas at Arlington, Department of Bioengineering, Arlington, USA (GRID:grid.267315.4) (ISNI:0000 0001 2181 9515)
2 Cook Children’s Health Care System, Jane and John Justin Institute for Mind Health Neurosciences Center, Fort Worth, USA (GRID:grid.470289.0)
3 Boston Children’s Hospital, Harvard Medical School, Fetal-Neonatal Neuroimaging and Developmental Science Center, Boston, USA (GRID:grid.2515.3) (ISNI:0000 0004 0378 8438)
4 Boston Children’s Hospital, Harvard Medical School, Division of Epilepsy Surgery, Department of Neurosurgery, Boston, USA (GRID:grid.2515.3) (ISNI:0000 0004 0378 8438)
5 Boston Children’s Hospital, Harvard Medical School, Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston, USA (GRID:grid.2515.3) (ISNI:0000 0004 0378 8438)
6 Cook Children’s Health Care System, Jane and John Justin Institute for Mind Health Neurosciences Center, Fort Worth, USA (GRID:grid.470289.0); The University of Texas at Arlington, Department of Bioengineering, Arlington, USA (GRID:grid.267315.4) (ISNI:0000 0001 2181 9515); Texas Christian University, School of Medicine, Fort Worth, USA (GRID:grid.264766.7) (ISNI:0000 0001 2289 1930)